VITRO DIAGNOSTIC TESTS

Brand	Owner (click to sort)	Address	Description
CALYPTE	Calypte Biomedical Corporation	16290 SW Upper Boones Ferry Rd. Portland OR 97224	in vitro diagnostic tests; namely, immunoassays;
MONOHAEM	AUSTRALIAN MONOCLONAL DEVELOPMENT PTY. LIMITED	65 DICKSON AVENUE ARTARMON, NEW SOUTH WALES Australia	IN VITRO DIAGNOSTIC TESTS FOR THE DETECTION OF FECAL OCCULT HEMOGLOBIN USING MONOCLONAL ANTIBODIES;
SENCELIA	PHARMACIA DIAGNOSTICS AB	Rapsgatan 7 Uppsala 75182 Sweden	IN VITRO DIAGNOSTIC TESTS TO BE USED AS AN AID IN THE DIAGNOSIS OF CELIAC DISEASE IN INTERNATIONAL CLASS 5.;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Appropriate determinations in a series of tests, which transition from more passive tests to more active tests, control the admission of data streams onto a network data path. More passive tests can include promiscuous mode and packet-pair tests. When the results of more passive tests indicate a reduce likelihood of a data stream causing a network data path to transition into a congested state, the network data path can be actively probed to make a more precise determination on the likelihood of congestion. A train of diagnostic data packets is transmitted at a diagnostic data transfer rate having a significantly reduced chance of causing congestion. A train of target data packets is transmitted at a requested application transfer data rate. The number of target data packets received within a specified delay threshold is compared to the number of diagnostic data packets receive with the delay threshold.